Companies

Moderna

Moderna is an mRNA therapeutics company that rose to prominence with its COVID-19 vaccine. Built on foundational research by Katalin Kariko and Drew Weissman, it is advancing an mRNA pipeline spanning infectious disease, oncology, rare diseases, and autoimmune conditions.

Details

Industry

Biotech

R&D Spend

$4.8B